Australia Has Already Spent over $100 Million Dealing with Varroa Mite. Here’s What We Can Do Next

Australia Has Already Spent over $100 Million Dealing with Varroa Mite. Here’s What We Can Do Next

The Conversation – Fashion (global)
The Conversation – Fashion (global)Jun 22, 2026

Why It Matters

The spread jeopardizes essential pollination services that underpin a large share of Australian food output and could drive up food prices; adopting RNAi could protect the industry while reducing reliance on failing chemicals.

Key Takeaways

  • Varroa established across eastern/southern Australia, eradication abandoned.
  • Chemical miticides show pyrethroid and amitraz resistance within four years.
  • Honeybee pollination underpins ~30% of Australian food, $9 bn value.
  • RNAi pesticide Norroa approved in US, pending Australian regulatory clearance.

Pulse Analysis

Australia’s beekeeping sector now faces a crisis that extends far beyond hobbyist apiaries. The Varroa destructor mite, once absent from the continent, has entrenched itself in the eastern and southern regions, directly threatening the pollination of crops that generate roughly US$9 billion annually. With more than a third of the nation’s food supply dependent on honeybee pollination, any collapse in colony health reverberates through supply chains, potentially inflating prices for consumers and eroding farm profitability.

Traditional chemical miticides, once the backbone of Varroa control, are losing efficacy as resistance to pyrethroids and amitraz spreads within just four years of the mite’s arrival. This resistance not only drives up treatment costs but also raises environmental concerns linked to repeated pesticide applications. In response, scientists are turning to RNA interference (RNAi), a biologically precise method that silences essential mite genes via sugar‑syrup delivery, offering a targeted, environmentally benign alternative that sidesteps the resistance mechanisms of conventional chemicals.

The pathway to widescale adoption hinges on regulatory approval and industry investment. The United States’ 2025 approval of Norroa, an RNAi‑based product that curtails mite reproduction, demonstrates commercial viability, yet its effectiveness is limited to low‑infestation scenarios. Australian authorities must evaluate similar solutions, balancing safety, specificity, and speed of action. Strategic funding for RNAi research, coupled with coordinated monitoring and beekeeper support, could safeguard pollination services, protect a multi‑billion‑dollar agricultural sector, and set a precedent for managing invasive pests globally.

Australia has already spent over $100 million dealing with Varroa mite. Here’s what we can do next

Comments

Want to join the conversation?

Loading comments...